Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dragonfly Therapeutics
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Stanford University
Bristol-Myers Squibb
Filamon LTD
Astellas Pharma Inc
Novartis
PMV Pharmaceuticals, Inc
Novartis
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
Hoffmann-La Roche
AstraZeneca
BeOne Medicines
Monte Rosa Therapeutics, Inc
Genmab
Thomas Jefferson University
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
Hummingbird Bioscience
University of California, Davis
Memorial Sloan Kettering Cancer Center
Replimune Inc.
Jazz Pharmaceuticals
Carevive Systems, Inc.
University of Pennsylvania
Duke University
University of Florida
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Clasp Therapeutics, Inc.
Ulsan University Hospital
Wake Forest University Health Sciences
Poseida Therapeutics, Inc.
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Poitiers University Hospital
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Centre Paul Strauss
Iambic Therapeutics, Inc